Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00724594 · ClinicalTrials.gov registry record · Phase 1
Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT00724594 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 46 participants.
The verdict
NCT00724594, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this trial was to find the best dose of N-acetylcysteine (NAC) to decrease brain injury in babies exposed to intrauterine infection without causing significant side effects.
Interventions
- DRUG N-acetylcysteine
- DRUG Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2008-08 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00724594
The ClinicalTrials.gov registry entry for NCT00724594 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which N-acetylcysteine is the first listed.
NCT00724594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00724594 about?
NCT00724594 is a clinical study titled "Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)". The purpose of this trial was to find the best dose of N-acetylcysteine (NAC) to decrease brain injury in babies exposed to intrauterine infection without causing significant side effects.
What is the current status of trial NCT00724594?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2008-08. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00724594?
The interventions under investigation include: N-acetylcysteine (DRUG), Control (DRUG).
Who is sponsoring clinical trial NCT00724594?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.